RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA
Clinical trials for RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA trials appear
Sign up with your email to follow new studies for RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
CAR T-Cell therapy takes on tough lymphoma in major trial
Disease control OngoingThis study tests a new treatment called axicabtagene ciloleucel (a CAR T-cell therapy) against standard treatments for people with follicular lymphoma that has returned or not responded to prior therapy. About 231 participants will be randomly assigned to receive either the CAR T…
Matched conditions: RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA
Phase: PHASE3 • Sponsor: Kite, A Gilead Company • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New hope for hard-to-treat lymphoma: experimental combo aims to keep cancer at bay
Disease control OngoingThis study tests whether adding the experimental drug tazemetostat to a standard two-drug therapy can help people with relapsed or refractory follicular lymphoma live longer without their cancer getting worse. About 555 adults whose lymphoma has returned or no longer responds to …
Matched conditions: RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA
Phase: PHASE3 • Sponsor: Epizyme, Inc. • Aim: Disease control
Last updated May 22, 2026 13:50 UTC